1. Home
  2. STKL vs RAPT Comparison

STKL vs RAPT Comparison

Compare STKL & RAPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SunOpta Inc.

STKL

SunOpta Inc.

HOLD

Current Price

$4.73

Market Cap

454.0M

ML Signal

HOLD

Logo RAPT Therapeutics Inc.

RAPT

RAPT Therapeutics Inc.

HOLD

Current Price

$57.60

Market Cap

498.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STKL
RAPT
Founded
1973
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
454.0M
498.4M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
STKL
RAPT
Price
$4.73
$57.60
Analyst Decision
Strong Buy
Buy
Analyst Count
2
10
Target Price
$7.75
$56.22
AVG Volume (30 Days)
1.1M
2.2M
Earning Date
02-25-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.01
N/A
Revenue
$792,436,000.00
N/A
Revenue This Year
$13.49
N/A
Revenue Next Year
$7.13
N/A
P/E Ratio
$110.28
N/A
Revenue Growth
11.95
N/A
52 Week Low
$3.32
$5.67
52 Week High
$7.68
$57.71

Technical Indicators

Market Signals
Indicator
STKL
RAPT
Relative Strength Index (RSI) 67.58 79.96
Support Level $3.60 $32.00
Resistance Level $5.01 $57.69
Average True Range (ATR) 0.22 1.27
MACD 0.07 2.52
Stochastic Oscillator 80.14 99.59

Price Performance

Historical Comparison
STKL
RAPT

About STKL SunOpta Inc.

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

Share on Social Networks: